GHRH analog raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-03-21. Anything still debated is marked as such rather than presented as settled.
A documented effect of tesamorelin is a reduction in visceral adipose tissue in some study populations. Researchers have reported decreases in trunk fat measured by computed tomography alongside changes in lipid markers. The mechanism is thought to involve growth hormone-mediated lipolysis, though the precise contribution of direct versus indirect pathways is not fully resolved. Studies have generally examined defined groups over finite periods, so long-term outcomes are less well characterized. Findings have not been uniform across all trials.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH). Its sequence corresponds to the 44-amino-acid form of human GHRH with a trans-3-hexenoyl group attached to the N-terminal tyrosine. This modification slows enzymatic cleavage and extends the peptide's activity relative to the native hormone. The compound is produced by solid-phase peptide synthesis and supplied as a lyophilized powder. Researchers classify it as a GHRH receptor agonist. Its structure places it in the same family as other growth hormone secretagogues that act on the pituitary.
Binding of tesamorelin to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and the release of growth hormone into circulation. Because the peptide acts upstream of the growth hormone axis, its effects are partly mediated by hepatic insulin-like growth factor 1 (IGF-1) production. The pulsatile character of endogenous growth hormone secretion is preserved rather than replaced. Whether amplified signaling produces effects beyond those of native GHRH remains an area of ongoing investigation.
Signaling begins at the GHRH receptor, a class B G protein-coupled receptor displayed on somatotroph cells of the anterior pituitary. Receptor occupancy activates Gs proteins, which raise adenylyl cyclase activity and intracellular cyclic AMP, in turn driving protein kinase A dependent pathways. The downstream output is synthesis and pulsatile secretion of growth hormone into the bloodstream. Hepatic tissue and peripheral sites respond by increasing insulin-like growth factor 1 production. Somatostatin and IGF-1 itself supply negative feedback that caps the size and duration of each secretory burst.
Metabolic interest in this compound centers on fat distribution rather than on hormone levels alone. Imaging trials in adults with excess abdominal fat report reductions in visceral adipose tissue, while subcutaneous depots change comparatively little. Growth hormone and IGF-1 are presumed to carry the effect, but the separate contribution of each is not firmly established. Whether these changes persist after treatment stops, and whether they alter longer-term health outcomes, remain open questions that published work does not answer consistently.
Tesamorelin is a synthetic peptide of forty-four amino acids whose sequence reproduces human growth hormone-releasing hormone. Its distinguishing feature sits at the amino terminus, where a trans-3-hexenoyl group replaces the free amine. That acylation slows cleavage by dipeptidyl peptidase IV, an enzyme that otherwise removes the first two residues and inactivates the natural hormone quickly. The modified peptide therefore persists longer in circulation while keeping the same receptor target. It is handled as a lyophilized solid and dissolved shortly before use.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | GHRH receptor agonist |
| Residue count | 44 amino acids | N-terminal trans-3-hexenoyl group |
| Approximate mass | About 5.1 kDa | Derived from the peptide sequence |
| Primary target | Pituitary GHRH receptor | Somatotroph cells of the anterior pituitary |
| Downstream marker | IGF-1 | Measured indirectly in circulation |
A Phase 3 program led to regulatory approval in the United States in 2010 for reduction of excess visceral abdominal fat in adults with HIV and lipodystrophy. Subsequent studies examined effects on liver fat, muscle area, and metabolic markers, with mixed findings for some endpoints. Long-term cardiovascular outcomes and effects on mortality remain uncertain because most trials were relatively short and focused on imaging-based fat measurements. Use in populations without HIV has been studied experimentally but is not part of the approved indication.
Tesamorelin is a synthetic analog of growth hormone-releasing hormone, a peptide hormone produced by the hypothalamus. The molecule retains the 44-amino-acid sequence of human GHRH and carries a trans-3-hexenoyl modification at its N-terminus. This modification increases resistance to enzymatic degradation and extends the peptide's functional stability relative to native GHRH. The compound is supplied as a lyophilized powder for reconstitution and subcutaneous administration in clinical settings. Its development code was TH9507, and it belongs to the GHRH analog class. It is not a growth hormone product; instead, it acts upstream to stimulate endogenous growth hormone release.
Several compounds share the GHRH framework, including sermorelin, the shorter 1-29 fragment, and other analogs built on the full 1-44 chain. Naming follows a common convention: a stem that identifies the peptide plus a suffix marking analog status. Reports may describe tesamorelin by its sequence fragment, as a GHRH(1-44) analog, or by its amino-terminal modification. Indexing the compound therefore requires searching all of these forms, since some older literature predates the current international nonproprietary name.
Tesamorelin is a synthetic peptide built from 44 amino acids and classified with the growth hormone–releasing hormone family. Its sequence corresponds to the human GHRH(1-44) backbone, carrying one structural change at the amino terminus. That change is a trans-3-hexenoyl group placed where the natural peptide would have an unmodified end. The modification is the feature that separates the compound from the endogenous hormone in name, in stability, and in how it is handled in the laboratory.
Several related peptides act on the same receptor, including sermorelin, a shorter GHRH fragment, and modified analogs such as CJC-1295 and modified GRF(1-29) that are common in research settings rather than approved products. Tesamorelin differs from growth hormone itself in that it acts upstream, prompting the pituitary to release the hormone through physiological signaling rather than supplying it directly. Terminology in the literature distinguishes GHRH analogs, growth hormone secretagogues, and recombinant growth hormone, although popular discussion often blurs these categories together. Precise naming matters when comparing study results.
Tesamorelin is a synthetic peptide of 44 amino acids that reproduces the sequence of human growth hormone-releasing hormone (GHRH) and carries a trans-3-hexenoyl group on its N-terminal tyrosine. That small fatty-acid modification blocks cleavage by dipeptidyl peptidase-4, the enzyme that rapidly degrades native GHRH in plasma. The result is a molecule with a longer circulating half-life than the natural hormone while retaining the same receptor target. It is supplied as a lyophilized powder for reconstitution and belongs to the broader class of GHRH analogs studied for effects on pituitary growth hormone secretion.
Development work on the compound, originally designated TH9507, focused on conditions in which reduced growth hormone signaling is thought to contribute to altered body composition. The United States Food and Drug Administration approved it in 2010 for the treatment of excess visceral abdominal fat in adults with human immunodeficiency virus infection and lipodystrophy. Later research examined other populations, including adults with mild cognitive impairment, where a large trial did not meet its primary endpoints. This mixed record illustrates how a single mechanism can produce clear effects in one setting and inconclusive results in another.
Tesamorelin is a synthetic peptide that belongs to the growth hormone-releasing hormone (GHRH) family. Its sequence corresponds to the fully active 44-amino-acid form of human GHRH, with a single structural modification: the addition of a trans-3-hexenoyl group at the N-terminus. That modification is not found in the naturally occurring hormone and was introduced deliberately during development to improve stability against enzymatic degradation. The compound is therefore best described as a stabilized analogue rather than a naturally occurring peptide.
The native hormone is produced in the hypothalamus and acts on the anterior pituitary. Binding of GHRH to its receptor stimulates synthesis and release of growth hormone into circulation. Because the analogue retains the receptor-binding region of the parent sequence, it engages the same receptor and triggers the same downstream signaling. The result is increased growth hormone secretion from pituitary cells, which in turn influences hepatic production of insulin-like growth factor 1. This axis is the basis for the compound's measured biological effects.
Interest in this peptide developed because native GHRH has a short circulating lifetime. The N-terminal modification slows cleavage by dipeptidyl peptidase IV, an enzyme that removes the first two residues of many peptides and terminates their activity. Slower degradation means a longer window of receptor stimulation per administration. This design logic parallels other modified peptide hormones, where a small chemical change at a vulnerable site yields a more durable molecule without altering the core mechanism of action.
=== Autoimmune conditions === The two main autoimmune conditions that impact the muscular system are myositis (including polymyositis and dermatomyositis), and myasthenia gravis. Hypotonia Loss of muscular tone or a diminished resistance to passive stretching. Myositis Inflammation of muscles Rhabdomyolysis Breakdown of skeletal muscle with release of intracellular contents
The half-life of uranium-236 is too short for it to be primordial, though it has been identified as an extinct progenitor of its alpha decay daughter, thorium-232. Uranium-236 occurs in spent nuclear fuel when neutron capture on 235U does not induce fission, or as a decay product of plutonium-240. Uranium-236 is not fertile, as three more neutron captures are required to produce fissile 239Pu, and is not itself fissile; as such, it is considered long-lived radioactive waste. Uranium-234 is a member of the uranium series and occurs in equilibrium with its progenitor, 238U; it undergoes alpha decay with a half-life of 245,500 years and decays to lead-206 through a series of relatively short-lived isotopes. Uranium-233 undergoes alpha decay with a half-life of 160,000 years and, like 235U, is fissile. It can be bred from thorium-232 via neutron bombardment, usually in a nuclear reactor; this process is known as the thorium fuel cycle. Owing to the fissility of 233U and the greater natural abundance of thorium (three times that of uranium), 233U has been investigated for use as nuclear fuel as a possible alternative to 235U and 239Pu, though is not in widespread use as of 2022. The decay chain of uranium-233 forms part of the neptunium series and ends at nearly-stable bismuth-209 (half-life 2.01×1019 years) and stable thallium-205. Uranium-232 is an alpha emitter with a half-life of 68.9 years. This isotope is produced as a byproduct in production of 233U and is considered a nuisance, as it is not fissile and decays through short-lived alpha and gamma emitters such as 208Tl.
=== Organizational === In management, behaviors are associated with desired or undesired focuses. Managers generally note what the desired outcome is, but behavioral patterns can take over. These patterns are the reference to how often the desired behavior actually occurs. Before a behavior actually occurs, antecedents focus on the stimuli that influence the behavior that is about to happen. After the behavior occurs, consequences fall into place. Consequences consist of rewards or punishments.
The movement for a single-island region started in the 1980s when officials of both provinces proposed a one-island, one-region unit. Negros Occidental and Negros Oriental are the only provinces in the Philippines situated in the same island but belonging to two different administrative regions with regional offices located in neighboring Panay and Cebu. The movement to unite the two provinces in Negros island was sustained in the 1990s and 2010s. The campaign for the creation of a region in Negros had gains when President Benigno Aquino III directed the Department of the Interior and Local Government (DILG) to study the establishment of a new region. with the government agency later endorsing the move. NEDA affirmed by saying that its studies show that the proposed region is economically viable. On May 29, 2015, President Aquino signed Executive Order 183, which created the Negros Island Region. It separated Negros Occidental and its capital Bacolod from Western Visayas (Region VI) and Negros Oriental from Central Visayas (Region VII) to form the island region, which made the total number of regions of the Philippines into 18.
Sources: en.wikipedia.org
The Poles supplied almost 100,000 men for the invasion force, but against their expectations, Napoleon avoided any concessions to Poland, having in mind further negotiations with Russia. The Grande Armée marched through Russia, winning some relatively minor engagements and the major Battle of Smolensk on 16–18 August. In the same days, part of the French Army led by Marshal Nicolas Oudinot was stopped in the Battle of Polotsk by the right wing of the Russian Army, under command of General Peter Wittgenstein. This prevented the French march on the Russian capital, Saint Petersburg; the fate of the invasion was decided in Moscow, where Napoleon led his forces in person.
Subcutaneous adipose tissue is also a source of mesenchymal stem cells and have demonstrated positive outcomes in terms of cardiovascular tissue remodeling. Mammal hearts also host naturally occurring cardiac stem cells which may be capable of differentiating themselves into cardiomyocytes, endothelial cells and cardiac fibroblasts. This self-regeneration capacity gives rise to alternatives to classical cellular therapies whereby administration of growth factors such as Thymosin β4 for cell activation and migration are solely necessary. Largely democratized in terms of population information, embryonic stem cells are known for their strong capacity for expansion and differentiation into cardiomyocytes, endothelial cells and cardiac fibroblasts. However, if non autologous, immunosuppression therapy is associated with such treatment. Hence, research has been focused on induced pluripotent stem cells (iPSCs) from somatic human tissue. Further to cell and necessary relevant growth factor selection, cell delivery is an important issue. Indeed, the intracoronary route is the most straightforward cell delivery route as associated with intramyocardial cellular retention; retention rates are however low, i.e. exceed 10%. Washed off cells reach other organs or die, which can be an issue at the time of prepare ICH module 8. Other alternative injection routes have been studied, namely injection via sternotomy, endomyocardial and intracoronary routes.
The adrenocorticotropic hormone receptor or ACTH receptor also known as the melanocortin receptor 2 or MC2 receptor is a type of melanocortin receptor (type 2) which is specific for ACTH. A G protein–coupled receptor located on the external cell plasma membrane, it is coupled to Gαs and upregulates levels of cAMP by activating adenylyl cyclase. The ACTH receptor plays a role in immune function and glucose metabolism.
State Life Insurance Corporation of Pakistan in the state owned life insurance company. It was formed in 1972 when life insurance business in Pakistan was nationalized and 32 life insurance companies were merged and consolidated.
Plants could grow greenhouses... just as turtles grow shells and polar bears grow fur and polyps build coral reefs in tropical seas. These plants could keep warm by the light from a distant Sun and conserve the oxygen that they produce by photosynthesis. The greenhouse would consist of a thick skin providing thermal insulation, with small transparent windows to admit sunlight. Outside the skin would be an array of simple lenses, focusing sunlight through the windows into the interior... Groups of greenhouses could grow together to form extended habitats for other species of plants and animals.
Sources: en.wikipedia.org
===== MeSH D08.811.913.817 – sulfur group transferases (EC 2.8) ===== MeSH D08.811.913.817.200 – coenzyme a-transferases MeSH D08.811.913.817.400 – sulfotransferases MeSH D08.811.913.817.400.300 – aryl sulfotransferase MeSH D08.811.913.817.500 – sulfurtransferases MeSH D08.811.913.817.500.500 – thiosulfate sulfurtransferase
Eric plans to have Jesse to sell his shares to Felim at the shoot, but Harper instead covertly helps Jesse buy a controlling stake in Rican from FutureDawn Partners, a socially conscious investment fund, seeing as Rican is underperforming and hiding it from Felim to ensure his investment. Felim, realizing Eric has yet again failed to deliver on his promises, cuts ties with him for good.
The announcement of the regulations which brought down the Wall took place at an hour-long press conference led by Günter Schabowski, the outgoing party leader in East Berlin and top party spokesman as Secretary for Information, beginning at 18:00 CET on 9 November and broadcast live on East German television and radio. Schabowski was joined by Minister of Foreign Trade Gerhard Beil and Central Committee members Helga Labs and Manfred Banaschak. Topics of the press conference included the results of votes at the Central Committee meeting, the surprising removal of SED Bezirk First Secretaries Hans-Joachim Böhme and Werner Walde, the SED's electoral and press reform plans and the new travel regulations. Schabowski had not been involved in the discussions about the new regulations and had not been fully updated. Shortly before the press conference, he was handed a note from Krenz announcing the changes, but given no further instructions on how to handle the information. The text stipulated that East German citizens could apply for permission to travel abroad without having to meet the previous requirements for those trips, and also allowed for permanent migration between all border crossings—including those between East and West Berlin. At 18:53, near the end of the press conference, ANSA's Riccardo Ehrman asked if the draft travel law of 6 November was a mistake.
In college basketball, the NCAA Division I men's and women's tournaments will expand to 76 teams beginning next year. The Pentagon releases declassified documents about UFOs and extraterrestrial life. May 10 – Six people are found dead inside a boxcar on a Union Pacific freight train in Laredo, Texas. May 12 2025–2026 United States redistricting: The Republican-led South Carolina Senate rejects redistricting efforts to redraw the congressional districts in South Carolina, including efforts to eliminate the seat represented by congressman Jim Clyburn. American autonomous driving technology company Waymo recalls 3,800 robotaxis over risks that they could enter flooded areas.
Their half-lives range from years to millions of years and as alpha emitters they are particularly radiotoxic. While there are proposed – and to a much lesser extent current – uses of all those elements, commercial-scale reprocessing using the PUREX-process disposes of them as waste together with the fission products. The waste is subsequently converted into a glass-like ceramic for storage in a deep geological repository. The duration that radioactive waste must be stored depends on the type of waste and radioactive isotopes it contains. Short-term approaches to radioactive waste storage have been segregation and storage on the surface or near-surface of the earth. Burial in a deep geological repository is a favored solution for long-term storage of high-level waste, while re-use and transmutation are favored solutions for reducing the HLW inventory. Boundaries to recycling of spent nuclear fuel are regulatory and economic as well as the problem of radioactive contamination if chemical separation processes cannot achieve a very high purity. Furthermore, elements may be present in both useful and troublesome isotopes, which would require costly and energy intensive isotope separation for their use – a currently uneconomic prospect. A summary of the amounts of radioactive waste and management approaches for most developed countries are presented and reviewed periodically as part of a joint convention of the International Atomic Energy Agency (IAEA).
Sources: en.wikipedia.org
It mirrors the 44-residue form of human growth hormone-releasing hormone. A hexenoyl group on the N-terminal tyrosine distinguishes it from the unmodified hormone. The change is intended to improve resistance to enzymatic breakdown.
The N-terminal modification reduces cleavage by circulating peptidases, so the peptide persists longer than native GHRH. That persistence is the main rationale for the synthetic design. Comparative half-life values in humans are reported in regulatory review documents rather than in general reference literature.
Reductions in visceral adipose tissue have been measured in controlled studies of defined populations. Whether the effect generalizes to other groups and persists after treatment stops is less clear. Longer-term outcome data remain limited.
The amino acid sequence matches human growth hormone-releasing hormone, but the amino terminus carries a trans-3-hexenoyl group instead of a free amine. That single structural change chiefly affects enzymatic stability rather than receptor selectivity.